Analystreport

vTv Therapeutics Inc (NASDAQ: VTVT) had its "hold" rating re-affirmed by analysts at Northland Securities. They now have a $3.00 price target on the stock.

vTv Therapeutics Inc. - Class A  (VTVT) 
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vtvtherapeutics.com